Logo image of WENA

ANEW MEDICAL INC (WENA) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:WENA - US7580831094 - Common Stock

0.726 USD
0 (-0.55%)
Last: 9/16/2024, 8:00:02 PM
0.755 USD
+0.03 (+3.99%)
After Hours: 9/16/2024, 8:00:02 PM

WENA Key Statistics, Chart & Performance

Key Statistics
Market Cap10.98M
Revenue(TTM)N/A
Net Income(TTM)-744.61K
Shares15.13M
Float3.16M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.03
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2022-04-29
Sector
GICS SectorFinancials
GICS IndustryFinancial Services
GICS IndustryGroupFinancial Services
GICS SubIndustrySpecialized Finance
WENA short term performance overview.The bars show the price performance of WENA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

WENA long term performance overview.The bars show the price performance of WENA in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of WENA is 0.726 USD. In the past month the price decreased by -30.86%.

ANEW MEDICAL INC / WENA Daily stock chart

WENA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to WENA.


Chartmill TA Rating
Chartmill Setup Rating

WENA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to WENA. WENA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

WENA Financial Highlights

Over the last trailing twelve months WENA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS decreased by -115.92% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -22.5%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-44.05%
Sales Q2Q%N/A
EPS 1Y (TTM)-115.92%
Revenue 1Y (TTM)N/A

WENA Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

WENA Ownership

Ownership
Inst Owners3.59%
Ins Owners8.49%
Short Float %N/A
Short RatioN/A

About WENA

Company Profile

WENA logo image ANEW Medical Inc is a US-based company operating in Financial Services industry. The company is headquartered in New York City, New York. The company went IPO on 2022-04-29. ANEW Medical, Inc. is a specialty pharmaceutical company. The firm specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The firm focuses on central nervous systems (CNS) diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease (AD), dementia symptoms and neuromuscular diseases. The firm has exclusive worldwide rights to develop and commercialize product platforms based on its proprietary isoform transcribed from the human Klotho gene referred to as secreted Klotho or s-KL. This s-KL protein or gene therapy has been recognized for its potential to mitigate age-related pathologies such as ALS, Alzheimer's and Parkinson's Disease. Its lead gene therapy product candidates are AMI-101 (AAV9-CMV-sKL) for the treatment or prevention of Alzheimer’s disease, and AMI-202 (AAVmyo-Des-sKL) gene therapy product for treatment and prevention of Lou Gehrig’s disease.

Company Info

ANEW MEDICAL INC

1115 Broadway, 12th Floor

New York City NEW YORK US

Employees: 0

WENA Company Website

Phone: 16469165315

ANEW MEDICAL INC / WENA FAQ

Can you describe the business of ANEW MEDICAL INC?

ANEW Medical Inc is a US-based company operating in Financial Services industry. The company is headquartered in New York City, New York. The company went IPO on 2022-04-29. ANEW Medical, Inc. is a specialty pharmaceutical company. The firm specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The firm focuses on central nervous systems (CNS) diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease (AD), dementia symptoms and neuromuscular diseases. The firm has exclusive worldwide rights to develop and commercialize product platforms based on its proprietary isoform transcribed from the human Klotho gene referred to as secreted Klotho or s-KL. This s-KL protein or gene therapy has been recognized for its potential to mitigate age-related pathologies such as ALS, Alzheimer's and Parkinson's Disease. Its lead gene therapy product candidates are AMI-101 (AAV9-CMV-sKL) for the treatment or prevention of Alzheimer’s disease, and AMI-202 (AAVmyo-Des-sKL) gene therapy product for treatment and prevention of Lou Gehrig’s disease.


Can you provide the latest stock price for ANEW MEDICAL INC?

The current stock price of WENA is 0.726 USD. The price decreased by -0.55% in the last trading session.


Does ANEW MEDICAL INC pay dividends?

WENA does not pay a dividend.


How is the ChartMill rating for ANEW MEDICAL INC?

WENA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


On which exchange is WENA stock listed?

WENA stock is listed on the Nasdaq exchange.


Can you provide the sector and industry classification for ANEW MEDICAL INC?

ANEW MEDICAL INC (WENA) operates in the Financials sector and the Financial Services industry.